References
- 1. Rahimi K, Emdin CA, MacMahon S. The epidemiology of blood pressure and its worldwide management. Circ Res. 2015; 116(6):925-936.
- 2. WHO Global Health Observatory Data Repository [online database]. Geneva, World Health Organization, 2013. (Accessed May 21, 2013, at site http://apps.who.int/gho/data/view.main).
- 3. Djordjic V, Radisavljevic S, Milanovic I, Bozic P, Grbic M, Jorga J, Ostojic SM. WHO European Childhood Obesity Surveillance Initiative in Serbia: a prevalence of overweight and obesity among 6-9-year-old school children. J Pediatr Endocrinol Metab. 2016; 29(9):1025-1030.
- 4. Bluher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013; 27(2):163-177.
- 5. Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016; 5:2048004016633371.
- 6. Nakamura K, Fuster JJ, Walsh K. Adipokines: A link between obesity and cardiovascular disease. Journal of human hypertension. 2014; 63(4): 250–259.
- 7. Seimon RV, Espinoza D, Ivers L, Gebski V, Finer N, Legler UF, Sharma AM, James WP, Coutinho W, Caterson ID. Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease. Int J Obes (Lond). 2014; 38(9):1165-1171.
- 8. Hall JE, Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms Circ Res. 2015; 116(6):991-1006.
- 9. Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010; 21(1):38–43.
- 10. Bluher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19(5):341–346.
- 11. Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, Muntner P. Visit-to-Visit Variability of Blood Pressure and Cardiovascular Disease and All-Cause Mortality. A Systematic Review and Meta-Analysis. Hypertension. 2014; 64(5):965-982.
- 12. Wang A, Li Z, Yang Y, Chen G, Wang C, Wu Y, Ruan C, Liu Y, Wang Y, Wu S. Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study. Ther Clin Risk Manag. 2016; 12:1191-1196.
- 13. Blacher J, Safar ME, Ly C, Szabo de Edelenyi F, Hercberg S, Galan P. Blood pressure variability: cardiovascular risk integrator or independent risk factor? J Hum Hypertens. 2015; 29(2):122-126.
- 14. Faramawi MF, Fischbach L, Delongchamp R, Cardenas V, Abouelenien S, Chedjieu IP, Taha N. Obesity is associated with visit-to-visit systolic blood pressure variability in the US adults. J Public Health (Oxf). 2015; 37(4):694–700.
- 15. Tadic M, Cuspidi C, Vukomanovic V, Kocijancic V, Celic V, Stanisavljevic D. The Association between Obesity, Blood Pressure Variability, and Right Ventricular Function and Mechanics in Hypertensive Patients. J Am Soc Echocardiogr. 2016; 29(8):802-811.
- 16. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25(6):1105-1187.
- 17. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H. European Guidelines for Obesity Management in Adults. Obes Facts. 2015; 8(6):402-424.
- 18. Schmieder RE, Messerli FH. Does obesity influence early target organ damage in hypertensive patients? Circulation 1993; 87(5):1482-1482.
- 19. Kannel WB, Zhang T, Garrison RJ. Is obesity related hypertension less of a cardiovascular risk? The Framingham Study. Am Heart J 1990; 120(5):1195-1201.
- 20. Juhanoja EP, Niiranen TJ, Johansson JK, Puukka PJ, Jula AM. Agreement between ambulatory, home, and office blood pressure variability. J Hypertens. 2016; 34(1):61-67.
- 21. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens 2013; 27(10):589–593.
- 22. Tai C, Sun Y, Dai N, Xu D, Chen W, Wang J. Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients. Hypertens (Greenwich). 2015; 17(2):107-115.
- 23. Poorolajal J, Hooshmand E, Bahrami M, Ameri P. How much excess weight loss can reduce the risk of hypertension? Public Health (Oxf) 2016; 133:14-18.
- 24. Luo WS, Guo ZR, Hu X, Zhou ZY, Wu M, Zhang LJ, Liu JC. Impact of dynamic change of waist circumference or body mass index in hypertension incidence. Zhonghua Yu Fang Yi Xue Za Zhi. 2011; 45(11):1012-1016
- 25. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Polo FH, Grassi G, Sega R. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007; 49(6):1265-1270.
- 26. Yano Y, Vongpatanasin W, Ayers C, Turer A, Chandra A, Carnethon MR, Greenlad P, de Lemos JA, Neeland IJ. Regional Fat Distribution and Blood Pressure Level and Variability. The Dallas Heart Study J. Neeland Hypertension. 2016; 68(3):576-583.
- 27. Jones A, Charakida M, Falaschetti E, Hingorani AD, Finer N, Masi S, Donald AE, Lawlor DA, Smith GD, Deanfield JE. Adipose and height growth through childhood and blood pressure status in a large prospective cohort study. Hypertension. 2012; 59(5):919–925.
- 28. Tu W, Eckert GJ, DiMeglio LA, Yu Z, Jung J, Pratt JH. Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension. 2011; 58:818– 824.
- 29. Raitakari M, Ilvonen T, Ahotupa M, Lehtimaki T, Harmoinen A, Suominen P, Juhani LE, Jaakko H, Olli TR. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004; 24:124–128.
- 30. Choe SS, Huh YJ, Hwang IJ, Kim JI, Kim JB. Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne) 2016; 7:30.
- 31. Siebenhofer A, Jeitler K, Horvath K, Berghold A, Siering U, Semlitsch T. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev 2013; (3):CD007654.
- 32. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens. 2013; 27:663–670.
- 33. Mulè G, Calcaterra I, Costanzo M, Geraci G, Guarino L, Foraci AC, Vario MG, Cerasola G, Cottone S. Relationship between short-term blood pressure variability and subclinical renal damage in essential hypertensive patients. J Clin Hypertens (Greenwich). 2015; 17(6):473– 480.